General Information

In the past decade we have experienced a veritable breakthrough in the management of inflammatory skin diseases, which were previously lacking satisfactory treatments. This revolution is particularly evident with introduction of novel targeted therapies for key inflammatory skin diseases, such as psoriasis, atopic dermatitis and an increasing number of other inflammatory conditions. This translational revolution stems from a growing knowledge of pathogenic pathways, and the advent of new technologies that are directly applicable to human biologic substrates. These ultimately led to the development of narrow therapeutics, and to their testing in clinical trials, further amplifying our current disease understanding. The organizing committee has taken the initiative to organize a symposium that directly addresses and describes these new developments.

This Symposium has been purposely designed to update the practicing dermatologist, MD-scientist, basic researcher and PhD student with a strong interest in translational research on the advances in this field. Information on novel therapeutics and disease concepts will not only cover psoriasis and eczema, but also other inflammatory skin diseases.

The Symposium will feature internationally recognized researchers who will provide new and updated information on disease mechanisms and management. The activity will address available data on outcomes so the physician can counsel patients about the risks and benefits of novel and upcoming treatment options. Learners will come away from the Symposium with renewed confidence in the latest dermatologic developments in the diagnosis of inflammatory skin diseases and new therapies allowing for effective treatment and ultimately improving clinical outcomes.

Target Audience

This activity is specifically designed for:

  • Dermatologists
  • MD-scientists
  • Basic researchers and PhD students with a strong interest in translational research

Objectives

At the conclusion of this activity, participants be able to:

  • Identify and analyze new and important studies on inflammatory skin diseases
  • Apply the most current research on the diagnosis and treatment of inflammatory skin diseases, including psoriasis and eczema
  • Compare and contrast new targeted therapies for inflammatory skin diseases, and apply them to their practice
  • Recognize, manage and appropriately treat unusual presentations of inflammatory skin diseases, based on newly developed personalized approaches